Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Study:

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Rationale:

n/a

Purpose:

To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Solid Tumors Drug: S-3304 Phase 1

Verified by Shionogi November, 2003

Sponsored by: Shionogi
Information provided by: Shionogi
ClinicalTrials.gov identifier: NCT00033215

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.